Description of mitochondrial oxygen tension and its variability in healthy volunteers

PLoS One. 2024 Jun 3;19(6):e0300602. doi: 10.1371/journal.pone.0300602. eCollection 2024.

Abstract

Objectives: Describing mitochondrial oxygenation (mitoPO2) and its within- and between-subject variability over time after 5-aminolevulinic acid (ALA) plaster application in healthy volunteers.

Design: Prospective cohort study.

Setting: Measurements were performed in Leiden University Medical Center, the Netherlands.

Participants: Healthy volunteers enrolled from July to September 2020.

Interventions: Two ALA plasters were placed parasternal left and right, with a 3-hour time interval, to examine the influence of the calendar time on the value of mitoPO2. We measured mitoPO2 at 4, 5, 7, 10, 28, and 31 hours after ALA plaster 1 application, and at 4, 5, 7, 25, and 28 hours after ALA plaster 2 application.

Primary and secondary outcome measures: At each time point, five mitoPO2 measurements were performed. Within-subject variability was defined as the standard deviation (SD) of the mean of five measurements per timepoint of a study participant. The between-subject variability was the SD of the mean mitoPO2 value of the study population per timepoint.

Results: In 16 completed inclusions, median mitoPO2 values and within-subject variability were relatively similar over time at all time points for both plasters. An increase in overall between-subject variability was seen after 25 hours ALA plaster time (19.6 mm Hg vs 23.9 mm Hg after respectively 10 and 25 hours ALA plaster time).

Conclusions: The mitoPO2 values and within-subject variability remained relatively stable over time in healthy volunteers. An increase in between-subject variability was seen after 25 hours ALA plaster time warranting replacement of the ALA plaster one day after its application.

Trial registration: ClinicalTrials.gov with trial number NCT04626661.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aminolevulinic Acid / administration & dosage
  • Female
  • Healthy Volunteers*
  • Humans
  • Male
  • Middle Aged
  • Mitochondria / metabolism
  • Netherlands
  • Oxygen Consumption
  • Oxygen* / metabolism
  • Prospective Studies
  • Young Adult

Substances

  • Aminolevulinic Acid
  • Oxygen

Associated data

  • ClinicalTrials.gov/NCT04626661

Grants and funding

This research was financially supported by Grant PPOC-16-31 by VWS-PPOC, Amsterdam, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.